189 related articles for article (PubMed ID: 24481673)
1. Attitudes of mothers of children with down syndrome towards noninvasive prenatal testing.
Kellogg G; Slattery L; Hudgins L; Ormond K
J Genet Couns; 2014 Oct; 23(5):805-13. PubMed ID: 24481673
[TBL] [Abstract][Full Text] [Related]
2. 'We would have missed out so much had we terminated': What fathers of a child with Down syndrome think about current non-invasive prenatal testing for Down syndrome.
How B; Smidt A; Wilson NJ; Barton R; Valentin C
J Intellect Disabil; 2019 Sep; 23(3):290-309. PubMed ID: 30021487
[TBL] [Abstract][Full Text] [Related]
3. Mothers of a child with Down syndrome: A qualitative analysis of the perspectives on non-invasive prenatal testing.
Valentin C; Smidt A; Barton R; Wilson NJ; How B
Midwifery; 2019 Sep; 76():118-124. PubMed ID: 31202107
[TBL] [Abstract][Full Text] [Related]
4. What Do Parents of Children with Down Syndrome Think about Non-Invasive Prenatal Testing (NIPT)?
van Schendel RV; Kater-Kuipers A; van Vliet-Lachotzki EH; Dondorp WJ; Cornel MC; Henneman L
J Genet Couns; 2017 Jun; 26(3):522-531. PubMed ID: 27618823
[TBL] [Abstract][Full Text] [Related]
5. Non-invasive prenatal testing for trisomy 21: a cross-sectional survey of service users' views and likely uptake.
Lewis C; Hill M; Silcock C; Daley R; Chitty LS
BJOG; 2014 Apr; 121(5):582-94. PubMed ID: 24433394
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive Prenatal Testing for Trisomies 21, 18, and 13, Sex Chromosome Aneuploidies, and Microdeletions: A Health Technology Assessment.
Health Quality Ontario
Ont Health Technol Assess Ser; 2019; 19(4):1-166. PubMed ID: 30847010
[TBL] [Abstract][Full Text] [Related]
7. Obstetric professionals' perceptions of non-invasive prenatal testing for Down syndrome: clinical usefulness compared with existing tests and ethical implications.
Ngan OMY; Yi H; Wong SYS; Sahota D; Ahmed S
BMC Pregnancy Childbirth; 2017 Sep; 17(1):285. PubMed ID: 28870159
[TBL] [Abstract][Full Text] [Related]
8. Has noninvasive prenatal testing impacted termination of pregnancy and live birth rates of infants with Down syndrome?
Hill M; Barrett A; Choolani M; Lewis C; Fisher J; Chitty LS
Prenat Diagn; 2017 Dec; 37(13):1281-1290. PubMed ID: 29111614
[TBL] [Abstract][Full Text] [Related]
9. Prenatal screening in the era of non-invasive prenatal testing: a Nationwide cross-sectional survey of obstetrician knowledge, attitudes and clinical practice.
Yang L; Tan WC
BMC Pregnancy Childbirth; 2020 Oct; 20(1):579. PubMed ID: 33004009
[TBL] [Abstract][Full Text] [Related]
10. Service provision of non-invasive prenatal testing for Down syndrome in public and private healthcare sectors: a qualitative study with obstetric providers.
Ngan OMY; Yi H; Ahmed S
BMC Health Serv Res; 2018 Sep; 18(1):731. PubMed ID: 30241520
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of preferences of women and healthcare professionals in Singapore for implementation of noninvasive prenatal testing for Down syndrome.
Barrett AN; Advani HV; Chitty LS; Su LL; Biswas A; Tan WC; Hill M; Choolani M
Singapore Med J; 2017 Jun; 58(6):298-310. PubMed ID: 27357315
[TBL] [Abstract][Full Text] [Related]
12. Women's preference for non-invasive prenatal DNA testing versus chromosomal microarray after screening for Down syndrome: a prospective study.
Cheng Y; Leung WC; Leung TY; Choy KW; Chiu R; Lo TK; Kwok KY; Sahota DS
BJOG; 2018 Mar; 125(4):451-459. PubMed ID: 29125674
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive detection of fetal trisomy 21: systematic review and report of quality and outcomes of diagnostic accuracy studies performed between 1997 and 2012.
Mersy E; Smits LJ; van Winden LA; de Die-Smulders CE; ; Paulussen AD; Macville MV; Coumans AB; Frints SG
Hum Reprod Update; 2013; 19(4):318-29. PubMed ID: 23396607
[TBL] [Abstract][Full Text] [Related]
14. Prenatal diagnosis, pregnancy terminations and prevalence of Down syndrome in Atlanta.
Siffel C; Correa A; Cragan J; Alverson CJ
Birth Defects Res A Clin Mol Teratol; 2004 Sep; 70(9):565-71. PubMed ID: 15368554
[TBL] [Abstract][Full Text] [Related]
15. Prenatal screening for Down syndrome in Australia: costs and benefits of current and novel screening strategies.
O'Leary P; Maxwell S; Murch A; Hendrie D
Aust N Z J Obstet Gynaecol; 2013 Oct; 53(5):425-33. PubMed ID: 24090461
[TBL] [Abstract][Full Text] [Related]
16. Receiving the news of Down syndrome in the era of prenatal testing.
Crombag NM; Page-Christiaens GC; Skotko BG; de Graaf G
Am J Med Genet A; 2020 Feb; 182(2):374-385. PubMed ID: 31863634
[TBL] [Abstract][Full Text] [Related]
17. The role of noninvasive prenatal testing as a diagnostic versus a screening tool--a cost-effectiveness analysis.
Ohno M; Caughey A
Prenat Diagn; 2013 Jul; 33(7):630-5. PubMed ID: 23674316
[TBL] [Abstract][Full Text] [Related]
18. National data on the early clinical use of non-invasive prenatal testing in public and private healthcare in Denmark 2013-2017.
Lund ICB; Petersen OB; Becher NH; Lildballe DL; Jørgensen FS; Ambye L; Skibsted L; Ernst A; Jensen AN; Fagerberg C; Brasch-Andersen C; Tabor A; Zingenberg HJ; Nørgaard P; Almind GJ; Vestergaard EM; Vogel I
Acta Obstet Gynecol Scand; 2021 May; 100(5):884-892. PubMed ID: 33230826
[TBL] [Abstract][Full Text] [Related]
19. Impact of early diagnosis and noninvasive prenatal testing (NIPT): Knowledge, attitudes, and experiences of parents of children with sex chromosome aneuploidies (SCAs).
Samango-Sprouse CA; Porter GF; Lasutschinkow PC; Tran SL; Sadeghin T; Gropman AL
Prenat Diagn; 2020 Mar; 40(4):470-480. PubMed ID: 31661555
[TBL] [Abstract][Full Text] [Related]
20. Health economic evaluation of noninvasive prenatal testing and serum screening for down syndrome.
Xiao G; Zhao Y; Huang W; Hu L; Wang G; Luo H
PLoS One; 2022; 17(4):e0266718. PubMed ID: 35421148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
